NL7209839A - - Google Patents

Info

Publication number
NL7209839A
NL7209839A NL7209839A NL7209839A NL7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A NL 7209839 A NL7209839 A NL 7209839A
Authority
NL
Netherlands
Application number
NL7209839A
Other versions
NL175618B (nl
NL175618C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NLAANVRAGE7209839,A priority Critical patent/NL175618C/xx
Priority to GB3213473A priority patent/GB1439225A/en
Priority to US00377978A priority patent/US3853838A/en
Priority to ZA734648A priority patent/ZA734648B/xx
Priority to CA176,197A priority patent/CA1019723A/en
Priority to AU57983/73A priority patent/AU471401B2/en
Priority to CH1025473A priority patent/CH605674A5/xx
Priority to DE2335826A priority patent/DE2335826C2/de
Priority to FR7325905A priority patent/FR2192838B1/fr
Priority to HUAO372A priority patent/HU169437B/hu
Priority to SE7309861A priority patent/SE392721B/xx
Priority to BE133475A priority patent/BE802335A/xx
Priority to JP48079221A priority patent/JPS5936611B2/ja
Publication of NL7209839A publication Critical patent/NL7209839A/xx
Publication of NL175618B publication Critical patent/NL175618B/xx
Application granted granted Critical
Publication of NL175618C publication Critical patent/NL175618C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NLAANVRAGE7209839,A 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden. NL175618C (nl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
GB3213473A GB1439225A (en) 1972-07-15 1973-07-05 Sedative peptides
US00377978A US3853838A (en) 1972-07-15 1973-07-10 Sedative peptides related to acth containing a d-phe moiety
ZA734648A ZA734648B (en) 1972-07-15 1973-07-10 Sedative peptides
AU57983/73A AU471401B2 (en) 1972-07-15 1973-07-11 Sedative peptides
CA176,197A CA1019723A (en) 1972-07-15 1973-07-11 Sedative peptides
CH1025473A CH605674A5 (th) 1972-07-15 1973-07-13
DE2335826A DE2335826C2 (de) 1972-07-15 1973-07-13 Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel
FR7325905A FR2192838B1 (th) 1972-07-15 1973-07-13
HUAO372A HU169437B (th) 1972-07-15 1973-07-13
SE7309861A SE392721B (sv) 1972-07-15 1973-07-13 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
BE133475A BE802335A (fr) 1972-07-15 1973-07-13 Nouveau peptide et son procede de preparation
JP48079221A JPS5936611B2 (ja) 1972-07-15 1973-07-13 ペプチドの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (3)

Publication Number Publication Date
NL7209839A true NL7209839A (th) 1974-01-17
NL175618B NL175618B (nl) 1984-07-02
NL175618C NL175618C (nl) 1984-12-03

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Country Status (13)

Country Link
US (1) US3853838A (th)
JP (1) JPS5936611B2 (th)
AU (1) AU471401B2 (th)
BE (1) BE802335A (th)
CA (1) CA1019723A (th)
CH (1) CH605674A5 (th)
DE (1) DE2335826C2 (th)
FR (1) FR2192838B1 (th)
GB (1) GB1439225A (th)
HU (1) HU169437B (th)
NL (1) NL175618C (th)
SE (1) SE392721B (th)
ZA (1) ZA734648B (th)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20130059914A1 (en) * 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (th) * 1961-05-04 1900-01-01
NL6509727A (th) * 1965-07-28 1967-01-30
GB1230472A (th) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
AU471401B2 (en) 1976-04-29
FR2192838A1 (th) 1974-02-15
SE392721B (sv) 1977-04-18
JPS5936611B2 (ja) 1984-09-05
NL175618B (nl) 1984-07-02
BE802335A (fr) 1974-01-14
CA1019723A (en) 1977-10-25
US3853838A (en) 1974-12-10
AU5798373A (en) 1975-01-16
JPS4951278A (th) 1974-05-18
CH605674A5 (th) 1978-10-13
DE2335826A1 (de) 1974-01-31
ZA734648B (en) 1974-06-26
DE2335826C2 (de) 1984-01-05
HU169437B (th) 1976-11-28
FR2192838B1 (th) 1977-01-28
NL175618C (nl) 1984-12-03
GB1439225A (en) 1976-06-16

Similar Documents

Publication Publication Date Title
JPS4978610A (th)
CS157575B1 (th)
CS158828B1 (th)
CS157372B1 (th)
CS159499B1 (th)
CS157351B1 (th)
CS158470B1 (th)
CS157993B1 (th)
CS156988B1 (th)
CS160385B1 (th)
JPS4956908U (th)
CS159690B1 (th)
CS159520B1 (th)
CS156978B1 (th)
CS156936B1 (th)
CS155030B1 (th)
CS153959B1 (th)
CS153905B1 (th)
CH566525A5 (th)
CH570921A5 (th)
CH576935A5 (th)
CH577017A5 (th)
CH579014A5 (th)
CH581117A5 (th)
CH582660A5 (th)

Legal Events

Date Code Title Description
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee